📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: InDex Pharmaceuticals

1.1 - Company Overview

InDex Pharmaceuticals Logo

InDex Pharmaceuticals

Headquarter: Sweden
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical immunotherapy R&D based on a toll-like receptor (TLR) platform, discovering and developing DNA-based immunomodulatory sequence (DIMS) drugs to treat diseases in therapeutic areas including inflammation and cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to InDex Pharmaceuticals

Abpro Logo

Abpro

HQ: United States Website
  • Description: Provider of next-generation antibody therapeutics, diagnostics, and research solutions using DiversImmune and MultiMab platforms to discover and engineer high-affinity, high-specificity bi- and multi-specific antibodies against difficult targets, including the TetraBi tetravalent bispecific format for T-cell engagement with bivalent tumor antigen binding, Fc modification, and flexible configurations to enhance safety and efficacy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Abpro company profile →
RhoVac Logo

RhoVac

HQ: Denmark Website
  • Description: Provider of an immuno-oncology therapeutic cancer vaccine targeting metastatic cancer cells by recognizing RhoC-overexpressing cells to stimulate an immune response (RV001, in clinical trials), plus oncology technologies: iCIP (LiPlaCis + DRP to identify cisplatin responders and deliver the drug with higher efficacy and less toxicity), LiPlaCis (liposomal cisplatin), and DRP (mRNA-based predictor of cisplatin response).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RhoVac company profile →
Hawaii Biotech Logo

Hawaii Biotech

HQ: United States Website
  • Description: Provider of biotechnology solutions focused on R&D of prophylactic vaccines for infectious diseases, including recombinant subunit vaccines (dengue, West Nile, Zika, tick-borne flaviviruses), viral hemorrhagic fevers (Crimean-Congo), and coronaviruses (SARS-CoV-2, pan-beta). Offers the GPI-0100 adjuvant, a protein production platform for vaccine development, and small molecule therapeutics for anthrax intoxication and botulism (BoNT type A).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hawaii Biotech company profile →
TomegaVax Logo

TomegaVax

HQ: United States Website
  • Description: Provider of an immunotherapy vaccine technology platform focused on preclinical and clinical development of vaccines and immunotherapies for chronic and recurring viral infections, including HIV and HPV, addressing unmet medical needs and pursuing cures for AIDS, herpes, papillomavirus and hepatitis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TomegaVax company profile →
Ankyra Therapeutics Logo

Ankyra Therapeutics

HQ: United States Website
  • Description: Provider of anchored immunotherapy for cancer treatments as a biotech company developing immunotherapy solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ankyra Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for InDex Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to InDex Pharmaceuticals

2.2 - Growth funds investing in similar companies to InDex Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for InDex Pharmaceuticals

4.2 - Public trading comparable groups for InDex Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to InDex Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About InDex Pharmaceuticals

What does InDex Pharmaceuticals do?

InDex Pharmaceuticals is a provider of clinical-stage biopharmaceutical immunotherapy R&D based on a toll-like receptor (TLR) platform, discovering and developing DNA-based immunomodulatory sequence (DIMS) drugs to treat diseases in therapeutic areas including inflammation and cancer.

Who are InDex Pharmaceuticals's competitors?

InDex Pharmaceuticals's competitors and similar companies include Abpro, RhoVac, Hawaii Biotech, TomegaVax, and Ankyra Therapeutics.

Where is InDex Pharmaceuticals headquartered?

InDex Pharmaceuticals is headquartered in Sweden.

How many employees does InDex Pharmaceuticals have?

InDex Pharmaceuticals has 1,000 employees 🔒.

When was InDex Pharmaceuticals founded?

InDex Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is InDex Pharmaceuticals in?

InDex Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for InDex Pharmaceuticals

Who are the top strategic acquirers in InDex Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in InDex Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for InDex Pharmaceuticals?

Top strategic M&A buyers groups and sectors for InDex Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in InDex Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in InDex Pharmaceuticals's sector and industry vertical?

Top PE firms investing in InDex Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in InDex Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in InDex Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in InDex Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to InDex Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in InDex Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for InDex Pharmaceuticals?

The key public trading comparables and valuation benchmarks for InDex Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for InDex Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for InDex Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in InDex Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for InDex Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in InDex Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in InDex Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for InDex Pharmaceuticals